Pantheon's shares have taken a battering this week on news that the Megrez-1 TS1 Target was predominantly water bearing. However, the company believe that data gathered, increases confidence in the productivity and hydrocarbon potential of the intervals higher with 5 futher intervals to test.

In little over a month, Oxford BioDynamics have inked two deals relating to the distribution and sales of its market leading Prostate Cancer PSE test. Does this mark the start of a turnaround for the company?

Blencowe Resources are entering a critical point in the valuation curve as they close out the last stages of the Orom-Cross DFS that will outline a 5 Phase approach to Blencowe becoming a major player in the critical minerals, graphite space.

With China tightening its grip on the Rare Earths Market (minerals required for the green transition and defence sectors), where can the west source these critical minerals outside of China? Well Harena listing on the UK stock market shortly could be part of the solution.

Veteran, 'company turn-around' specialist Iain Ross recently joined Oxford BioDynamics as Chairman.  His mandate, to take a leading 3D Genomics company with a commercial-ready portfolio into the mainstream market-place via industry deals and partnerships.   "I've never in-herited a portfolio like this", Chairman, Iain Ross. 

Pitch yourself against other traders or your friends in the SmallCapPix Blazing Trader Fantasy Stock Challenge. The lucky winner will bank £100 in prize money and earn 4 League Points and a place in the coveted SmallCapPix Stock Challenges Leage Table when the challenge closes end of June.